09:42:40 EDT Tue 22 Sep 2020
Enter Symbol
or Name

Login ID:

Cannabis Summary for Dec. 30, 2019

2019-12-30 20:00 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index gained 8.07 points to 387.68 Monday. Sonny Newman's C21 Investments Inc. (CXXI) lost eight cents to 78 cents on 790,000 shares after releasing its results for the fiscal third quarter ended Oct. 31, 2019. The United States-based cannabis producer lost $5.1-million (U.S.) on revenue of $10.5-million (U.S.) in Q3, down from a loss of $2.9-million (U.S.) on revenue of $9.8-million (U.S.) in fiscal Q2. While the Q3 loss was worse, it included a $4.1-million (U.S.) asset writedown. In fact, C21's expenses in the third quarter were $3.2-million (U.S.), down from $4.3-million (U.S.) in Q2.

Today's fall puts C21's stock back near 75 cents, where it started 2019. It has been a rocky year for C21 shareholders. As was the case for many cannabis companies, C21 surged in the first three months of the year. It hit a high of $2.52 at the end of March, but those gains did not last long. The company tumbled to a low of 45 cents in October and has since rebounded to 78 cents.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.